An observational study in Cardiogenic Shock and Pulmonary Edema Cardiac Cause, sponsored by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA). Not yet recruiting. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-04.
Sponsored by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Accurate hemodynamic monitoring is critical in cardiothoracic surgery, where left atrial pressure (LAP) serves as the gold standard for assessing left-sided cardiac filling pressures. However, its invasive nature limits use, favoring pulmonary capillary wedge pressure (PCWP) via Swan-Ganz catheter as a surrogate. Despite widespread use, evidence on their agreement under dynamic conditions-such as varying cardiac index (CI) flows during cardiopulmonary bypass (CPB) or left ventricular (LV) unloading-remains inconsistent and unstudied in adult cardiac surgery.
Existing data show conflicting correlations: one study found that PCWP 35% higher than LAP in non-surgical patients, and another study found closer alignment in specific cohorts. This knowledge gap carries clinical urgency, as decisions on pulmonary edema management, vasopressor use, and LV decompression rely on these measurements.
Building on Laplace's law, we hypothesize that LV unloading reduces ventricular wall stress (afterload), lowering myocardial oxygen demand and altering the LAP-PCWP relationship. Elevated CI during CPB may further distort this interaction via increased pulmonary-left atrial pressure gradients.
The primary objective is to determine if PCWP reliably reflects LAP under standard CI-flow (2.4 L/min/m²) without unloading, using Bland-Altman analysis (±5 mmHg clinical margin). Secondary objectives assess agreement at other CI levels (1.8-2.6 L/min/m²), LV unloading effects, and patient/surgical variable impacts.
Effective hemodynamic monitoring is essential for optimizing postoperative management in cardiothoracic surgery. Left atrial pressure (LAP) is considered the gold standard for assessing left-sided cardiac filling pressures, but is typically measured directly only in selected cases due to its invasive nature. Pulmonary capillary wedge pressure (PCWP), measured via a Swan-Ganz catheter, is widely used as a less invasive surrogate for LAP. However, evidence suggests that the agreement between PCWP and directly measured LAP may vary under different hemodynamic conditions, particularly at higher cardiac index (CI) flow rates and with or without left ventricular (LV) unloading. To date, no in-vivo study has systematically quantified the agreement between these two methods in adult patients during cardiopulmonary bypass (CPB) at varying flow rates and unloading conditions.
Existing studies report inconsistent correlations between LAP and PCWP. For example, one study observed PCWP values 35% higher than LAP in non-surgical patients, while another study noted tighter correlations in specific cohorts. However, no in-vivo data exist for adult cardiac surgery patients under controlled CI-flow rates (+/- LV unloading). This gap is clinically critical, as decisions regarding pulmonary edema management, vasopressor use, and LV decompression rely on these measurements.
Building on Laplace's law, we hypothesize that LV unloading reduces ventricular wall stress (afterload), thereby lowering myocardial oxygen demand and improving recovery. Computational models and animal studies suggest that unloading decreases LV end-diastolic pressure (LVEDP) and left atrial (LA) volume, which may alter the LAP-PCWP relationship. Elevated CI during CPB could further modulate this interaction, as increased flow rates may exacerbate pressure gradients between the pulmonary vasculature and left atrium.
The primary objective of our study is therefore to determine whether PCWP can be considered an adequate surrogate for directly measured LAP under standard CI-flow (2.4 L/min/m²) without LV unloading, using a Bland-Altman analysis. Secondary objectives include evaluating the agreement between LAP and PCWP at other CI-flow rates and with LV unloading, as well as exploring the influence of patient characteristics and surgical variables. By addressing these questions, we hope to provide evidence to guide the interpretation of PCWP in clinical practice, potentially improving the safety and outcomes of patients undergoing cardiac surgery.
297 studies on the registry are indexed under Shock, Cardiogenic; 134 are open to participants now.
This study's planned enrollment of 136 is below the median of 200 across 156 observational studies indexed under Shock, Cardiogenic.
Browse Shock, Cardiogenic studies →Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) is the lead sponsor of 533 studies on the registry; 182 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Adult patients undergoing elective cardiac surgery for aortic valve regurgitation, mitral valve, coronary or aortic disease. We aim to include patients without significant impairment in cardiac function. Nonetheless, there are inherent primary and secondary effects of cardiac pathology leading to structural disease. The procedures, as noted in the inclusion criteria (4.2), are standard procedures in our hospital and are regularly performed. We want to select the patient from our wait list. No extra measures are taken to include the patients.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The share of blood the heart’s main pumping chamber (the left ventricle) pushes out with each beat, measured by an echocardiogram (heart ultrasound) or a MUGA scan. About 50–70% is normal.
LVEF (left ventricular ejection fraction)
The share of blood the heart’s main pumping chamber (the left ventricle) pushes out with each beat, measured by an echocardiogram (heart ultrasound) or a MUGA scan. About 50–70% is normal.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Patients with and without LV unloading under different cardiac indeces via cardiopulmonary bypass
Mean Difference (Bias) Between Left Atrial Pressure (LAP) and Pulmonary Capillary Wedge Pressure (PCWP) at a Cardiac Index of 2.4 L/min/m² Without LV Unloading
Mean difference (bias) between invasively measured left atrial pressure (LAP, mmHg) and pulmonary capillary wedge pressure (PCWP, mmHg) at a fixed cardiac index of 2.4 L/min/m² without left ventricular unloading. Agreement will be assessed using Bland-Altman analysis. The mean difference (LAP minus PCWP) will be reported with 95% limits of agreement. PCWP will be considered an adequate surrogate for LAP if the 95% limits of agreement fall within ±5 mmHg. Unit of measure: mmHg.
Time frame: Intraoperatively
Mean Difference (Bias) Between LAP and PCWP at Different Cardiac Index Flow Rates and LV Unloading Conditions
Mean difference (bias) between invasively measured left atrial pressure (LAP, mmHg) and pulmonary capillary wedge pressure (PCWP, mmHg) for each cardiac index flow rate and LV unloading condition. Agreement will be assessed per condition using Bland-Altman analysis. The mean difference (LAP minus PCWP) will be reported with 95% limits of agreement. Unit of measure: mmHg.
Time frame: Intraoperatively
Correlation Coefficient Between LAP and PCWP at Different Cardiac Index Flow Rates and LV Unloading Conditions
Correlation between invasively measured left atrial pressure (LAP, mmHg) and pulmonary capillary wedge pressure (PCWP, mmHg) for each cardiac index flow rate and LV unloading condition. One correlation coefficient will be reported per condition, using Pearson's r or Spearman's ρ depending on data distribution. Unit of measure: correlation coefficient (unitless, range -1 to 1).
Time frame: Intraoperatively
Change in Left Atrial Pressure (LAP) Before and After Mitral Valve Surgery
Change in invasively measured left atrial pressure (LAP, mmHg) from before to after mitral valve surgery in mitral valve patients, calculated as the post-procedure value minus the pre-procedure value. Values will be compared using a paired t-test or Wilcoxon signed-rank test, depending on data distribution. Unit of measure: mmHg.
Time frame: Intraoperatively
Change in Pulmonary Capillary Wedge Pressure (PCWP) Before and After Mitral Valve Surgery
Change in invasively measured pulmonary capillary wedge pressure (PCWP, mmHg) from before to after mitral valve surgery in mitral valve patients, calculated as the post-procedure value minus the pre-procedure value. Values will be compared using a paired t-test or Wilcoxon signed-rank test, depending on data distribution. Unit of measure: mmHg.
Time frame: Intraoperatively
Correlation Coefficient Between Echocardiographic Left Ventricular End-Diastolic Volume (LVEDV) and Invasive LAP and PCWP
Correlation between left ventricular end-diastolic volume (LVEDV, mL), measured by echocardiography, and invasively measured left atrial pressure (LAP, mmHg) and pulmonary capillary wedge pressure (PCWP, mmHg). Two correlation coefficients will be reported (LVEDV vs LAP and LVEDV vs PCWP) using Pearson's r or Spearman's ρ, depending on data distribution. Unit of measure: correlation coefficient (unitless, range -1 to 1).
Time frame: Intraoperatively
Correlation Coefficient Between Echocardiographic Left Ventricular Wall Thickness and Invasive LAP and PCWP
Correlation between left ventricular wall thickness as a measure of LV hypertrophy (mm), measured by echocardiography, and invasively measured left atrial pressure (LAP, mmHg) and pulmonary capillary wedge pressure (PCWP, mmHg). Two correlation coefficients will be reported (wall thickness vs LAP and wall thickness vs PCWP) using Pearson's r or Spearman's ρ, depending on data distribution. Unit of measure: correlation coefficient (unitless, range -1 to 1).
Time frame: Intraoperatively
Correlation Coefficient Between Echocardiographic Left Ventricular Ejection Fraction (LVEF) and Invasive LAP and PCWP
Correlation between left ventricular ejection fraction (LVEF, %), measured by echocardiography, and invasively measured left atrial pressure (LAP, mmHg) and pulmonary capillary wedge pressure (PCWP, mmHg). Two correlation coefficients will be reported (LVEF vs LAP and LVEF vs PCWP) using Pearson's r or Spearman's ρ, depending on data distribution. Unit of measure: correlation coefficient (unitless, range -1 to 1).
Time frame: Intraoperatively
Correlation Coefficient Between Echocardiographic E/e' Ratio and Invasive LAP and PCWP
Correlation between the E/e' ratio (unitless), a measure of left-sided diastolic filling pressure measured by echocardiography, and invasively measured left atrial pressure (LAP, mmHg) and pulmonary capillary wedge pressure (PCWP, mmHg). Two correlation coefficients will be reported (E/e' vs LAP and E/e' vs PCWP) using Pearson's r or Spearman's ρ, depending on data distribution. Unit of measure: correlation coefficient (unitless, range -1 to 1).
Time frame: Intraoperatively
Correlation Coefficient Between Echocardiographic Tricuspid Annular Plane Systolic Excursion (TAPSE) and Invasive LAP and PCWP
Correlation between tricuspid annular plane systolic excursion (TAPSE, mm), a measure of right ventricular performance measured by echocardiography, and invasively measured left atrial pressure (LAP, mmHg) and pulmonary capillary wedge pressure (PCWP, mmHg). Two correlation coefficients will be reported (TAPSE vs LAP and TAPSE vs PCWP) using Pearson's r or Spearman's ρ, depending on data distribution. Unit of measure: correlation coefficient (unitless, range -1 to 1).
Time frame: Intraoperatively
Correlation Coefficient Between Echocardiographic Mitral Regurgitation Grade and Invasive LAP and PCWP
Correlation between mitral regurgitation severity (ordinal grade 1-4), graded by echocardiography, and invasively measured left atrial pressure (LAP, mmHg) and pulmonary capillary wedge pressure (PCWP, mmHg). Two correlation coefficients will be reported (MR grade vs LAP and MR grade vs PCWP) using Spearman's ρ, since MR grade is an ordinal variable. Unit of measure: correlation coefficient (unitless, range -1 to 1).
Time frame: Intraoperatively
Correlation Coefficient Between Echocardiographic Left Atrial Volume Index (LAVI) and Invasive LAP and PCWP
Correlation between left atrial volume index (LAVI, mL/m²), measured by echocardiography, and invasively measured left atrial pressure (LAP, mmHg) and pulmonary capillary wedge pressure (PCWP, mmHg). Two correlation coefficients will be reported (LAVI vs LAP and LAVI vs PCWP) using Pearson's r or Spearman's ρ, depending on data distribution. Unit of measure: correlation coefficient (unitless, range -1 to 1).
Time frame: Intraoperatively
Correlation Coefficient Between Echocardiographic Right Atrial Volume Index (RAVI) and Invasive LAP and PCWP
Correlation between right atrial volume index (RAVI, mL/m²), measured by echocardiography, and invasively measured left atrial pressure (LAP, mmHg) and pulmonary capillary wedge pressure (PCWP, mmHg). Two correlation coefficients will be reported (RAVI vs LAP and RAVI vs PCWP) using Pearson's r or Spearman's ρ, depending on data distribution. Unit of measure: correlation coefficient (unitless, range -1 to 1).
Time frame: Intraoperatively
Correlation Coefficient Between Echocardiographic Left Ventricular Outflow Tract (LVOT) Dimensions and Invasive LAP and PCWP
Correlation between left ventricular outflow tract (LVOT) dimensions (mm), measured by echocardiography, and invasively measured left atrial pressure (LAP, mmHg) and pulmonary capillary wedge pressure (PCWP, mmHg). Two correlation coefficients will be reported (LVOT dimensions vs LAP and LVOT dimensions vs PCWP) using Pearson's r or Spearman's ρ, depending on data distribution. Unit of measure: correlation coefficient (unitless, range -1 to 1).
Time frame: Intraoperatively
No study locations are listed for this record.
Plan to share: No
No publications or documents are linked to this record.
Start is estimated for Sep 2028; primary completion for Jun 2029, 9 months later.
Of 79 non-industry observational studies under Shock, Cardiogenic, half reached primary completion within 44 months of starting (the median), counting those still running; a quarter within 19. This study's planned 9 months is below that.
Counting every sponsor, half of 85 studies reached it within 45 months; a quarter within 24.
Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 4, 2026: start Sep 2025 → Sep 2028, primary completion Jun 2026 → Jun 2029 and completion Oct 2026 → Oct 2030.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) →